Serum Institute of India’s Adar Poonawalla recently announced that he has set aside ₹10 crore to fund the mandatory quarantine stipulation for Indian students studying abroad.

PHILANTHROPY: Adar Poonawalla sets aside ₹10 crore to help Indian students quarantine abroad 

:

(August 9, 2021) Serum Institute of India’s Adar Poonawalla recently announced that he has set aside ₹10 crore to fund the mandatory quarantine stipulation for Indian students studying abroad. Given that SII’s Covishield, the Indian version of the Oxford-AstraZeneca vaccine is yet to get approval for travel without quarantine in some countries, Poonawalla has decided to lend a helping hand to students looking to join their universities.  

“Dear students travelling abroad, as a few countries are yet to approve COVISHIELD as an acceptable vaccine for travel without quarantine, you may have to incur some costs. I have set aside Rs10 crore for this, apply below for financial support if needed,” Poonawalla tweeted last week. 

According to the stipulation, Indian students will have to undergo a 10-day quarantine at a place of their choosing as they travel abroad to join university. Only those who have been fully vaccinated in the UK, EU, and USA will be exempted from quarantine. Although the WHO has cleared Covishield for emergency use, it is yet to get approval from the European Medicines Agency. On the other hand, Bharat Biotech’s Covaxin, the other vaccine in use in India, is yet to receive an emergency use listing from the WHO.

Also Read: Learning: How this UK-based startup’s founder is upskilling Kashmiri youth

Share with

Got Covaxin jab? Some US universities require re-vaccination

(Our Bureau, June 8) Some American universities are asking Indian students that were administered Covaxin or Sputnik V jabs to get themselves re-vaccinated before starting classes. The reason: Covaxin and Sputnik V don’t have World Health

Dr Ashish Jha: The straight-talking dean and pandemic expert

Dr Ashish Jha is known for his unbiased, play-it-straight approach to healthcare. With a cocktail of research, persuasion, and a witty Twitter feed, the Indian American has been driving health care improvements for more th

How MIT scientist Shriya Srinivasan’s ventilator tech is saving lives

When Shriya Srinivasan, a postdoctoral medical researcher at 

Meet Jonathan Iralu, the Naga-origin doctor who has a day dedicated to him in New Mexico

(July 29, 2021; 5.45 pm) Back in March 2020, even before the first case of COVID-19 was recorded in US' New Mexico state, an Indian-origin infectious disease specialist was hard

Dr Nikhila Juvvadi: 32-year-old chief clinical officer who gave Chicago its first Covid-19 jab

Dr Nikhila Juvvadi and her team at the 122-bed Loretto Hospital in Chicago had their task cut out when Covid-19 engulfed the US last year. 

At one stage, Chicago's 6